BDSX logo

Biodesix, Inc. (BDSX)

Profile

Full Name

Biodesix, Inc.

Ticker

NASDAQ: BDSX

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

October 28, 2020

Indexes

Not included

Website

https://www.biodesix.com

Employees

273

Key Details

Price

$7.60(+1926.67%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$71.32M(+45.30% YoY)

Annual EPS

-$0.33(+48.44% YoY)

PE ratio

-

Next earnings date

Oct 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $7.60
    BDSX price is $7.60

    30-Day Relative Volume

    0.04
    BDSX 30-day relative volume is 0.04

    Price Performance

    Price Today change

    +1926.67%
    BDSX price is up +1926.67% today

    Price YTD change

    +396.73%
    BDSX price is up +396.73% since January 1st

    Price 1-year change

    +329.38%
    BDSX price is up +329.38% year-on-year

    Price 3-year change

    +363.41%
    BDSX price is up +363.41% over the past 3 years

    Price Range

    Price All-time high

    $31.99
    BDSX price is currently -76.24% below its historical high of $31.99

    Price 3-year low

    $0.17
    BDSX price is currently +4318.60% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $55.72M
    BDSX market capitalization is $55.72 million

    Market cap 3-year change

    +1599.57%
    BDSX market capitalization is up +1599.57% over the past 3 years

    Market cap All-time high

    $55.72M
    BDSX market capitalization is currently at an all-time high

    Market cap sector rank

    33.72%
    BDSX market capitalization is higher than 33.72% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +1%
    BDSX shares outstanding is up +1% year-on-year

    Shares Outstanding 3-Year Change

    +266.75%
    BDSX shares outstanding is up +266.75% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    2.54
    BDSX beta is 2.54

    200-day SMA

    $0.73
    BDSX price is currently +946.54% above its 200-day simple moving average

    50-day SMA

    $0.54
    BDSX price is currently +1310.54% above its 50-day simple moving average

    RSI

    97.24
    BDSX 14-day relative strength index is 97.24

    Volume

    0.04
    BDSX 30-day relative volume is 0.04

    ATR

    $0.59
    BDSX average true range is $0.59

    10-day Historical Volatility

    9677.82%
    BDSX 10-day historical volatility is 9677.82%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $71.32M
    BDSX annual revenue is $71.32 million

    Revenue Analysts estimate

    $83.06M
    BDSX annual revenue is currently -14.13% lower than the consensus analysts' forecast

    Revenue 1-year change

    +45.3%
    BDSX annual revenue is up +45.3% year-on-year

    Revenue Sector rank

    65.56%
    BDSX annual revenue is higher than 65.56% of companies in Healthcare sector

    EPS

    EPS

    -$0.33
    BDSX annual earnings per share is -$0.33

    EPS Analysts estimate

    -$0.28
    BDSX annual earnings per share is currently +16.81% higher than the consensus analysts' forecast

    EPS 1-year change

    +48.44%
    BDSX annual earnings per share is up +48.44% year-on-year

    EPS Sector rank

    67.23%
    BDSX annual earnings per share is higher than 67.23% of companies in Healthcare sector

    Profit

    Gross profit

    $55.75M
    BDSX annual gross profit is $55.75 million

    Gross margin

    78.17%
    BDSX annual gross profit margin is 78.17%

    Operating profit

    -$34.26M
    BDSX annual operating income is -$34.26 million

    Operating margin

    -48.04%
    BDSX annual operating profit margin is -48.04%

    Net income

    -$42.93M
    BDSX annual net profit is -$42.93 million

    Net margin

    -60.19%
    BDSX annual net profit margin is -60.19%

    Expenses

    Total expenses

    $105.58M
    BDSX annual total expenses is $105.58 million

    Operating expenses

    $90.01M
    BDSX annual total operating expenses is $90.01 million

    Cost of goods sold

    $15.57M
    BDSX annual cost of goods sold is $15.57 million

    Selling, general & administrative expenses

    $80.45M
    BDSX annual SGA is $80.45 million

    Depreciation and amortization

    $5.46M
    BDSX annual depreciation & amortization is $5.46 million

    Interest expense

    $8.26M
    BDSX annual interest expense is $8.26 million

    Income tax

    $0.00
    BDSX annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$34.67M
    BDSX annual earnings before interest & taxes is -$34.67 million

    EBITDA

    -$29.22M
    BDSX annual EBITDA is -$29.22 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $99.18M
    BDSX annual total assets is $99.18 million

    Non current assets

    $57.76M
    BDSX annual long term assets is $57.76 million

    Current assets

    $39.48M
    BDSX annual total current assets is $39.48 million

    Cash and cash equivalents

    $26.25M
    BDSX annual cash & cash equivalents is $26.25 million

    Accounts receivable

    $8.60M
    BDSX annual accounts receivable is $8.60 million

    Inventory

    $1.00M
    BDSX annual inventory is $1.00 million

    Liabilities

    Total liabilities

    $78.30M
    BDSX annual total liabilities is $78.30 million

    Long term liabilities

    $62.05M
    BDSX annual total long term liabilities is $62.05 million

    Current liabilities

    $14.32M
    BDSX annual total current liabilities is $14.32 million

    Accounts payable

    $2.19M
    BDSX annual accounts payable is $2.19 million

    Debt

    Total debt

    $61.98M
    BDSX annual total debt is $61.98 million

    Total debt 1-year change

    +2.12%
    BDSX annual total debt is up +2.12% year-on-year

    Long term debt

    $61.24M
    BDSX annual long term debt is $61.24 million

    Short term debt

    $740.00K
    BDSX annual short term debt is $740.00 thousand

    Equity & Capital

    Shareholders equity

    $20.88M
    BDSX annual stockholders equity is $20.88 million

    Book value

    $20.88M
    BDSX annual book value is $20.88 million

    Retained earnings

    -$462.50M
    BDSX annual retained earnings is -$462.50 million

    Working capital

    $25.17M
    BDSX annual working capital is $25.17 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$48.65M
    BDSX annual cash flow from operations is -$48.65 million

    Cash from operations 1-year change

    -112.72%
    BDSX annual cash flow from operations is down -112.72% year-on-year

    Cash from investing

    -$3.44M
    BDSX annual cash flow from investing activities is -$3.44 million

    Cash from investing 1-year change

    +85.08%
    BDSX annual cash flow from investing activities is up +85.08% year-on-year

    Cash from financing

    $52.05M
    BDSX annual cash flow from financing activities is $52.05 million

    Cash from financing 1-year change

    +78.69%
    BDSX annual cash flow from financing activities is up +78.69% year-on-year

    CAPEX

    CAPEX

    $3.44M
    BDSX annual capital expenditures is $3.44 million

    CAPEX 1-year change

    -85.08%
    BDSX annual capital expenditures is down -85.08% year-on-year

    Free Cash Flow

    Free cash flow

    -$52.09M
    BDSX annual free cash flow is -$52.09 million

    Free cash flow 1-year change

    -13.4%
    BDSX annual free cash flow is down -13.4% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    78.17%
    BDSX annual gross profit margin is 78.17%

    Operating margin

    -48.04%
    BDSX annual operating profit margin is -48.04%

    Net margin

    -60.19%
    BDSX annual net profit margin is -60.19%

    ROA & ROE

    ROA

    -43.30%
    BDSX annual return on assets is -43.30%

    ROE

    -337.30%
    BDSX annual return on equity is -337.30%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BDSX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BDSX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    48.99
    BDSX price to book ratio is 48.99

    PB ratio Sector rank

    97.56%
    BDSX price to book ratio is higher than 97.56% of companies in Healthcare sector

    PS Ratio

    PS ratio

    0.73
    BDSX price to sales ratio is 0.73

    PS ratio Sector rank

    16.34%
    BDSX price to sales ratio is higher than 16.34% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $107.03M
    BDSX enterprise value is $107.03 million

    Enterprise value Sector rank

    47.42%
    BDSX enterprise value is higher than 47.42% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -3.81
    BDSX EV/EBITDA is -3.81

    EV/EBITDA Sector rank

    26.88%
    BDSX EV/EBITDA is higher than 26.88% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    2.76
    BDSX annual current ratio is 2.76

    Quick ratio

    2.69
    BDSX annual quick ratio is 2.69

    Leverage

    Debt to equity

    1.75
    BDSX annual debt to equity ratio is 1.75

    Interest coverage ratio

    -4.20
    BDSX annual interest coverage ratio is -4.20

    Risk & Stability

    Piotroski F-Score

    3
    BDSX piotroski f-score is 3

    Altman Z-Score

    -6.23
    BDSX altman z-score is -6.23

    Analyst ratings

    Recent major analysts updates

    May 21, 25 Scotiabank
    Sector Outperform
    May 14, 25 William Blair
    Market Perform
    May 14, 25 Lake Street
    Buy
    May 14, 25 Craig-Hallum
    Buy
    May 14, 25 Canaccord Genuity
    Buy
    Apr 29, 25 Canaccord Genuity
    Buy
    Sep 16, 24 Scotiabank
    Sector Outperform
    Jul 26, 24 Craig-Hallum
    Buy
    May 13, 24 TD Cowen
    Buy
    May 3, 24 Lake Street
    Buy

    Institutional Ownership

    Screeners with BDSX included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    Stocks above analysts price target
    • What is the ticker symbol for Biodesix, Inc.?
    • Does Biodesix, Inc. pay dividends?
    • What sector is Biodesix, Inc. in?
    • What industry is Biodesix, Inc. in?
    • What country is Biodesix, Inc. based in?
    • When did Biodesix, Inc. go public?
    • Is Biodesix, Inc. in the S&P 500?
    • Is Biodesix, Inc. in the NASDAQ 100?
    • Is Biodesix, Inc. in the Dow Jones?
    • When was Biodesix, Inc.'s last earnings report?
    • When does Biodesix, Inc. report earnings?

    What is the ticker symbol for Biodesix, Inc.?

    The ticker symbol for Biodesix, Inc. is NASDAQ:BDSX

    Does Biodesix, Inc. pay dividends?

    No, Biodesix, Inc. does not pay dividends

    What sector is Biodesix, Inc. in?

    Biodesix, Inc. is in the Healthcare sector

    What industry is Biodesix, Inc. in?

    Biodesix, Inc. is in the Diagnostics & Research industry

    What country is Biodesix, Inc. based in?

    Biodesix, Inc. is headquartered in United States

    When did Biodesix, Inc. go public?

    Biodesix, Inc.'s initial public offering (IPO) was on October 28, 2020

    Is Biodesix, Inc. in the S&P 500?

    No, Biodesix, Inc. is not included in the S&P 500 index

    Is Biodesix, Inc. in the NASDAQ 100?

    No, Biodesix, Inc. is not included in the NASDAQ 100 index

    Is Biodesix, Inc. in the Dow Jones?

    No, Biodesix, Inc. is not included in the Dow Jones index

    When was Biodesix, Inc.'s last earnings report?

    Biodesix, Inc.'s most recent earnings report was on August 7, 2025

    When does Biodesix, Inc. report earnings?

    The next expected earnings date for Biodesix, Inc. is October 30, 2025
    On this page